Both in Pharmaceuticals
Prothena vs DiaMedica Therapeutics
Over the past year PRTA returned −10.0% and DMAC returned +18.7%; their daily moves had a correlation of 0.31.
PRTA −10.0% DMAC +18.7%Growth of $1, one year, split-adjusted
| Metric | PRTA | DMAC |
|---|---|---|
| Price | $8.78 | $8.20 |
| Market cap | $450.7M | $442.2M |
| Today | +0.69% | −1.44% |
| 1 month | −5.9% | +28.3% |
| 6 months | −5.1% | +23.5% |
| Year to date | −8.1% | +3.0% |
| 1 year | −6.7% | +18.2% |
| Revenue growth (YoY) | −77.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −1839.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.3× | — |
| Net cash | $288.2M | $43.5M |
| Dividend yield | — | — |
| Volatility (60d) | 41.5% | 43.2% |
| Short % of float | 20.2% | 22.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).